Besides the well-characterised modulators of CDK1, our analysis highlights a novel potential role for MYO3A, GSK3A and GRK6 kinases, whose expression profile is highly correlated with CDK1 itself and its modulators across cancer tissues. The gene discussed is MYO3A; the disease is cancer.